535 filings
Page 5 of 27
8-K
0964tsm4c5d0r0
30 Apr 21
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
9tt24j
18 Mar 21
Additional proxy soliciting materials
5:04pm
8-K
oe0n lj5o
4 Feb 21
Departure of Directors or Certain Officers
5:00pm
8-K
wmy0252
21 Jan 21
Entry into a Material Definitive Agreement
5:14pm
424B5
nea5knefv eo
21 Jan 21
Prospectus supplement for primary offering
5:11pm
S-3MEF
zcj0j
20 Jan 21
Registration of additional securities for an S-3
9:59pm
424B5
hv18kiv8s gv
20 Jan 21
Prospectus supplement for primary offering
5:05pm
8-K
rozsu zs9
19 Jan 21
Entry into a Material Definitive Agreement
5:00pm
8-K
rkdowg2h3adhc 79
13 Nov 20
OncoSec Announces Positive Interim Data from
5:15pm
8-K
z2t0rq
29 Oct 20
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
5:00pm
8-K
tzq6azg630cmk
13 Oct 20
Departure of Directors or Certain Officers
5:15pm
424B5
rmr15jy0x80 kw
17 Aug 20
Prospectus supplement for primary offering
11:04am
8-K
d4cv ns69
17 Aug 20
Entry into a Material Definitive Agreement
9:36am
8-K
g9za6ouqncbkj0d46
27 Jul 20
Departure of Directors or Certain Officers
4:30pm